Related content

Complications after prostate brachytherapy in the Medicare population - morbidity and complications

By Benoit R.M.   Naslund M.J.   Cohen J.K.  

Urology, Vol. 55, Iss. 1, 2000-01 ,pp. : 91-96

Elsevier

Access to resources Recommend Favorite

Permanent prostate brachytherapy-induced morbidity in patients with grade II and III obesity

By Merrick G.S.   Butler W.M.   Wallner K.   Galbreath R.W.   Anderson R.L.   Kurko B.S.   Lief J.H.  

Urology, Vol. 60, Iss. 1, 2002-07 ,pp. : 104-108

Elsevier

Access to resources Recommend Favorite

Iodine-125 brachytherapy for localized prostate cancer and urinary morbidity: a prospective comparison of two seed implant methods-preplanning and intraoperative planning

By Matzkin H.   Kaver I.   Stenger A.   Agai R.   Esna N.   Chen J.  

Urology, Vol. 62, Iss. 3, 2003-09 ,pp. : 497-502

Elsevier

Access to resources Recommend Favorite

Neoadjuvant hormonal therapy and older age are associated with adverse sexual health-related quality-of-life outcome after prostate brachytherapy

By Hollenbeck B.K.   Dunn R.L.   Wei J.T.   McLaughlin P.W.   Han M.   Sanda M.G.  

Urology, Vol. 59, Iss. 4, 2002-04 ,pp. : 480-484

Elsevier

Access to resources Recommend Favorite

Complications Following Permanent Prostate Brachytherapy

By Stone N.N.   Stock R.G.  

European Urology, Vol. 41, Iss. 4, 2002-04 ,pp. : 427-433

Elsevier

Access to resources Recommend Favorite